Inhibition of Interleukin-1 in the Treatment of Selected Cardiovascular Complications.
Fatemeh Sadat HeydariSimin ZareAli Roohbakhsh
Published in: Current reviews in clinical and experimental pharmacology (2022)
The present review article shows that IL-1β has a major role in the pathophysiology of cardiovascular disorders, its antagonists have beneficial effects in these conditions, and their use should be considered in future studies.